05/27/2026 | Press release | Distributed by Public on 05/27/2026 18:45
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option (Right to Buy) | $0.9 | 05/22/2026 | M | 545,824 | (9) | 06/05/2034 | Common Stock | 545,824 | $ 0 | 5,404,556 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Kinsella Matthew John C/O INFLEQTION, INC. 1315 WEST CENTURY DRIVE, SUITE 150 LOUISVILLE, CO 80027 |
X | Chief Executive Officer | ||
| /s/ Jason D. Hall, Attorney-in-Fact | 05/27/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.8226 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| (2) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.83 to $17.8293 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| (3) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.83 to $18.1651 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| (4) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.675 to $17.995 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| (5) | Held directly by Kinsella Investment Holdings, LLC. Mr. Kinsella may be deemed to beneficially own shares of Kinsella Investment Holdings, LLC by virtue of his voting power and investment power over such shares. |
| (6) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| (7) | Held directly by The John R. Kinsella Children's Trust, of which the Reporting Person is co-trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Children's Trust by virtue of his voting power and investment power over such shares. |
| (8) | Held directly by The John R. Kinsella Revocable Living Trust, of which the Reporting Person is a trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Revocable Living Trust by virtue of his voting power and investment power over such shares. |
| (9) | Fully vested. |
|
Remarks: The shares of common stock reported as sold represent less than 9.0% of the shares of common stock beneficially owned by the Reporting Person immediately prior to the sales as reported on this Form 4. Following the sales as reported on this Form 4, the Reporting Person continues to beneficially own shares of common stock representing approximately 3.4% of the Issuer's outstanding common stock. For purposes of this remark, beneficial ownership is determined in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended, and percentages are calculated based on 221,099,150 shares of common stock of the Issuer outstanding as of May 22, 2026, plus (i) 7,870,316 shares of common stock issuable to the Reporting Person upon the exercise of vested options as of such date and (ii) 20,071 shares of common stock issuable to the Reporting Person upon the exercise of options, or the vesting of restricted stock units, within 60 days of such date. |
|